Everence Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Everence Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$67	Sell
2022 Q3	$153K	Hold
2022 Q2	$181K	Buy
2022 Q1	$96K	Buy
2018 Q1	–	Sell
2017 Q4	$606K	Hold
2017 Q3	$244K	Hold
2017 Q2	$198K	Hold
2017 Q1	$238K	Buy